Trial NCT03776864

View at ClinicalTrials.gov 
Org. Study IDs: RG1003718
Secondary IDs: 10075 NCI-2018-02836

Last trial update was posted on 2023-05-03

MeSH Interventions

Immunoglobulin G Immunoglobulins Pembrolizumab

MeSH Conditions

Hodgkin Disease Lymphoma

Other Conditions

Hodgkin's Lymphoma

Stopping Reasons

Company providing drug terminated their oncology program

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID